BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 30602726)

  • 1. Chromatin regulatory mechanisms and therapeutic opportunities in cancer.
    Valencia AM; Kadoch C
    Nat Cell Biol; 2019 Feb; 21(2):152-161. PubMed ID: 30602726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutated Chromatin Regulatory Factors as Tumor Drivers in Cancer.
    Koschmann C; Nunez FJ; Mendez F; Brosnan-Cashman JA; Meeker AK; Lowenstein PR; Castro MG
    Cancer Res; 2017 Jan; 77(2):227-233. PubMed ID: 28062403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consolidation of the cancer genome into domains of repressive chromatin by long-range epigenetic silencing (LRES) reduces transcriptional plasticity.
    Coolen MW; Stirzaker C; Song JZ; Statham AL; Kassir Z; Moreno CS; Young AN; Varma V; Speed TP; Cowley M; Lacaze P; Kaplan W; Robinson MD; Clark SJ
    Nat Cell Biol; 2010 Mar; 12(3):235-46. PubMed ID: 20173741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploiting epigenetic vulnerabilities in solid tumors: Novel therapeutic opportunities in the treatment of SWI/SNF-defective cancers.
    Chabanon RM; Morel D; Postel-Vinay S
    Semin Cancer Biol; 2020 Apr; 61():180-198. PubMed ID: 31568814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FACER: comprehensive molecular and functional characterization of epigenetic chromatin regulators.
    Lu J; Xu J; Li J; Pan T; Bai J; Wang L; Jin X; Lin X; Zhang Y; Li Y; Sahni N; Li X
    Nucleic Acids Res; 2018 Nov; 46(19):10019-10033. PubMed ID: 30102398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromatin dependencies in cancer and inflammation.
    Marazzi I; Greenbaum BD; Low DHP; Guccione E
    Nat Rev Mol Cell Biol; 2018 Apr; 19(4):245-261. PubMed ID: 29184195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis.
    Gupta RA; Shah N; Wang KC; Kim J; Horlings HM; Wong DJ; Tsai MC; Hung T; Argani P; Rinn JL; Wang Y; Brzoska P; Kong B; Li R; West RB; van de Vijver MJ; Sukumar S; Chang HY
    Nature; 2010 Apr; 464(7291):1071-6. PubMed ID: 20393566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromatin regulators with tumor suppressor properties and their alterations in human cancers.
    Shu XS; Li L; Tao Q
    Epigenomics; 2012 Oct; 4(5):537-49. PubMed ID: 23130835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Keystone Symposia on Epigenomics and Chromatin Dynamics: Keystone resort, CO, January 17-22, 2012.
    Ravnskjaer K
    Epigenetics; 2012 May; 7(5):522-3. PubMed ID: 22491067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation and chromatin modifiers in colorectal cancer.
    Vymetalkova V; Vodicka P; Vodenkova S; Alonso S; Schneider-Stock R
    Mol Aspects Med; 2019 Oct; 69():73-92. PubMed ID: 31028771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linking the epigenetic 'language' of covalent histone modifications to cancer.
    Hake SB; Xiao A; Allis CD
    Br J Cancer; 2004 Feb; 90(4):761-9. PubMed ID: 14970850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Functions of Histone Modification Enzymes in Cancer.
    Wang R; Xin M; Li Y; Zhang P; Zhang M
    Curr Protein Pept Sci; 2016; 17(5):438-45. PubMed ID: 26796305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical regulation of epigenetic modifications: opportunities for new cancer therapy.
    Zheng YG; Wu J; Chen Z; Goodman M
    Med Res Rev; 2008 Sep; 28(5):645-87. PubMed ID: 18271058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small Molecular Inhibitors Targeting Chromatin Regulating Proteins for Cancer.
    Luan J; Chu Z; Chandra J; Zhang P
    Curr Protein Pept Sci; 2016; 17(5):455-62. PubMed ID: 26796303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular biology. Genetic events that shape the cancer epigenome.
    Ryan RJ; Bernstein BE
    Science; 2012 Jun; 336(6088):1513-4. PubMed ID: 22723401
    [No Abstract]   [Full Text] [Related]  

  • 16. Histone modifications and cancer.
    Sawan C; Herceg Z
    Adv Genet; 2010; 70():57-85. PubMed ID: 20920745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations of Chromatin Structure Regulating Genes in Human Malignancies.
    Chen J; Herlong FH; Stroehlein JR; Mishra L
    Curr Protein Pept Sci; 2016; 17(5):411-37. PubMed ID: 26796307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic alterations in cancer.
    Ilango S; Paital B; Jayachandran P; Padma PR; Nirmaladevi R
    Front Biosci (Landmark Ed); 2020 Mar; 25(6):1058-1109. PubMed ID: 32114424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromatin signatures of cancer.
    Morgan MA; Shilatifard A
    Genes Dev; 2015 Feb; 29(3):238-49. PubMed ID: 25644600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromatin remodeling in cancer: a gateway to regulate gene transcription.
    Nair SS; Kumar R
    Mol Oncol; 2012 Dec; 6(6):611-9. PubMed ID: 23127546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.